Biolistic DNA vaccination against melanoma

Methods in Molecular Biology

Volumn 940, Issue , 2013, Pages 317-337

  Steitz, Julia ^a   Tüting, Thomas ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

CD8+ T cells; DNA vaccine; Melanoma; TRP2; Vitiligo

Indexed keywords

BETA GALACTOSIDASE; CANCER VACCINE; DNA VACCINE; DOPACHROME ISOMERASE; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; GOLD; GREEN FLUORESCENT PROTEIN; ISOMERASE; TUMOR ANTIGEN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOLISTIC TRANSFORMATION; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL MELANOMA; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INSTRUMENTATION; LUNG TUMOR; METABOLISM; METASTASIS; MOUSE; PIGMENTATION; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BETA-GALACTOSIDASE; BIOLISTICS; BLOTTING, WESTERN; CANCER VACCINES; FEMALE; GOLD; GREEN FLUORESCENT PROTEINS; HUMANS; INTERFERON-GAMMA; INTRAMOLECULAR OXIDOREDUCTASES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; PIGMENTATION; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA;

MURINAE;

EID: 84870482375     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-110-3_24     Document Type: Article

References (22)

1. Tang DC, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154
2. Donnelly JJ et al (1997) DNA vaccines. Annu Rev Immunol 15:617-648
3. Tüting T et al (1998) Autologous human monocyte-derived dendritic cells genetically modi fied to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-Alpha. J Immunol 160:1139-1147
4. Tüting T, Albers A (2000) Particle-mediated gene transfer into dendritic cells: a novel strategy for the induction of immune responses against tumor antigens. Methods Mol Med 35:27-47
5. Condon C et al (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2:1122-1128
6. Tüting T et al (1999) Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective antI-melanoma immunity. J Gene Med 1:400-406
7. Corr M et al (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184:1555-1560
8. Boon T, van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729
9. Rosenberg SA (1997) Cancer vaccines based on the identi fication of genes encoding cancer regression antigens. Immunol Today 18:175-182
10. Schreurs MW et al (1998) Genetic vaccination against the melanocyte lineage-speci fic antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection. Cancer Res 58:2509-2514
11. Weber LW et al (1998) Tumor immunity and autoimmunity induced by immunization with homologous DNA. J Clin Invest 102:1258-1264
12. Steitz J et al (2000) Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma. Int J Cancer 86:89-94
13. Bowne WB et al (1999) Coupling and uncoupling of tumor immunity and autoimmunity. J Exp Med 190:1717-1722
14. Steitz J et al (2002) Genetic immunization with a melanocytic self-Antigen linked to foreign helper sequences breaks tolerance and induces autoimmunity and tumor immunity. Gene Ther 9:208-213
15. Kameyama K et al (1993) Pigment production in murine melanoma cells is regulated by tyrosinase, tyrosinase-related protein 1 (TRP1), DOPAchrome tautomerase (TRP2), and a melanogenic inhibitor. J Invest Dermatol 100:126-131
16. Steitz J et al (2006) Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination. Cancer Gene Ther 13:318-325
17. Gaffal E et al (2007) Comparative evaluation of CD8 + CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells. Eur J Cell Biol 86:817-826
18. Lane C et al (2004) Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin. Cancer Res 64:1509-1514
19. Scheibenbogen C, Hunstein W, Keilholz U (1994) Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients. Eur J Cancer 30A:1209-1211
20. Irvine KR et al (1996) Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156:238-245
21. Okamoto T et al (1998) AntI-tyrosinaserelated protein-2 immune response in vitiligo patients and melanoma patients receiving active-speci fic immunotherapy. J Invest Dermatol 111:1034-1039
22. Steitz J et al (2004) Initiation and regulation of CD8 + T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur J Cell Biol 83:797-803